Elkayam L, Matalon A, Tseng CH, Axelrod F. Prevalence and severity of renal disease in familial dysautonomia. severity of renal disease in familial dysautonomia. Am J Kidney Dis. 2006;48:780–786.
Ngai J, Kreynin I, Kim JT, Axelrod FB. Anesthesia management of familial dysautonomia. Paediatr Anaesth. 2006;16:611–620.
Axelrod FB. Familial dysautonomia. Muscle Nerve. 2004;29: 352–363.
Axelrod FB, Nachtigal R, Dancis J. Familial dysautonomia: diagnosis, pathogenesis and management. Adv Pediatr. 1974;21: 75–96.
Axelrod FB. Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin Pharmacother. 2005;6:561–567.
Weingarten TN, Sprung J, Burgher AH. Perioperative management of familial dysautonomia: a systematic review. Eur J Anaesthesiol. 2007;24:309–316.
Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999;54:146–165.
Frumento RJ, Logginidou HG, Wahlander S, Wagener G, Playford HR, Sladen RN. Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J Clin Anesth. 2006;18:422–426.
Billings FT, Chen SW, Kim M, Park SW, Song JH, Wang S, Herman J, D’Agati V, Lee HT. Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:F741–F748.